EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)

Hepatitis B–CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

Rachel K Russ, Haley M Vandehei, Maria I Golovkina, Harshitha Mogallapalli, Freddy Caldera iD, Mary S Hayney iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae320 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Rachel K Russ und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Health Personnel, Hepatitis B, Hepatitis B Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Dynavax Technologies Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This prospective study enrolled healthcare workers (HCWs) who were nonresponders following at least 5 doses of aluminum-adjuvanted hepatitis B vaccine who received the 2-dose Heplisav-B (HepB-CpG) (Dynavax Technologies Corporation, Emeryville, CA) series. After 2 doses of HepB-CpG, 43/47 (91%) participants, and with 1 dose, 41/49 (84%) responded. HepB-CpG could be the preferred vaccine in HCW nonresponders. Clinical Trials Registration. Clinicaltrials.gov NCT04456504.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelHepatitis BHepatitis B VaccinesAdultFemaleHumansMaleMiddle AgedYoung AdultAdjuvants, ImmunologicHepatitis B AntibodiesProspective StudiesVaccination

Stichwörter der Autor:innen

healthcare workershepatitis B vaccinehepatitis B vaccine-CpG adjuvantnonrespondersseroprotections

Substanzen

Adjuvants, ImmunologicHepatitis B AntibodiesHepatitis B Vaccines

Autor:innen und Institutionen

  • School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Employee Health Services, UW Health, Madison, Wisconsin, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.

ORCID-Profile: Freddy Caldera, Mary S Hayney

Förderung

  • Dynavax Technologies Corporation

Zitieren

APA

Russ, R. K., Vandehei, H. M., Golovkina, M. I., Mogallapalli, H., Caldera, F., & Hayney, M. S. (2024). Hepatitis B–CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae320

Vancouver

Russ RK, Vandehei HM, Golovkina MI, Mogallapalli H, Caldera F, Hayney MS. Hepatitis B–CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae320

BibTeX
@article{Russ2024,
  author = {Russ, Rachel K and Vandehei, Haley M and Golovkina, Maria I and Mogallapalli, Harshitha and Caldera, Freddy and Hayney, Mary S},
  title = {Hepatitis B–CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae320}
}
Kostenlos starten →